David A. Smith
Impact in
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
- Hepatology top 5%
- Hepatitis C virus research
Papers in
-
- Hepatitis B Virus Studies 5
- Liver Disease Diagnosis and Treatment 3
- Oncology 8
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Thomas G. Lowe (5 shared papers)Michael O’Brien (4 shared papers)A. David Tahernia (1 shared paper)Stephen Falk (1 shared paper)Justin S. Waters (1 shared paper)Gary Middleton (1 shared paper)Wasat Mansoor (1 shared paper)David Ferry (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Journal of the American Medical Directors Association (4 papers)Spine (4 papers)Journal of Hepatology (2 papers)PLoS ONE (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
David A. Smith
52 papers receiving 1.5k citations
David A. Smith's Hit Papers
Peers
Comparison fields: 5 of 105
- Gastroenterology 138
- Hepatology 152
- Pathology and Forensic Medicine 292
- Pulmonary and Respiratory Medicine 393
- Oncology 327
Countries citing papers authored by David A. Smith
This map shows the geographic impact of David A. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Smith more than expected).
Fields of papers citing papers by David A. Smith
This network shows the impact of papers produced by David A. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Smith. The network helps show where David A. Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside David A. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial Hit paper breakdown → | 2013 | 551 |
| 2 | 2002 | 186 | |
| 3 | 2017 | 80 | |
| 4 | 2014 | 59 | |
| 5 | 2002 | 55 | |
| 6 | 2018 | 53 | |
| 7 | 1992 | 42 | |
| 8 | 1991 | 40 | |
| 9 | 2018 | 39 | |
| 10 | 2003 | 36 | |
| 11 | 2018 | 32 | |
| 12 | 1995 | 27 | |
| 13 | 2020 | 23 | |
| 14 | 2009 | 22 | |
| 15 | 2019 | 20 | |
| 16 | 2021 | 19 | |
| 17 | 1993 | 19 | |
| 18 | 2020 | 19 | |
| 19 | 2012 | 18 | |
| 20 | 2005 | 18 |
About David A. Smith
David A. Smith is a scholar working on Epidemiology, Oncology, Hepatology, Surgery and Molecular Biology, having authored 53 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (5 papers), Iron Metabolism and Disorders (3 papers), Scoliosis diagnosis and treatment (3 papers), Cancer Genomics and Diagnostics (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Gastroenterology (138 citations), Hepatology (152 citations), Pathology and Forensic Medicine (292 citations), Pulmonary and Respiratory Medicine (393 citations) and Oncology (327 citations). David A. Smith has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Thomas G. Lowe, Michael O’Brien, A. David Tahernia, Stephen Falk, Justin S. Waters, Gary Middleton, Wasat Mansoor, David Ferry, Jonathan Wadsley and Sarah Slater. Their work appears in journals such as Journal of Clinical Oncology, Journal of the American Medical Directors Association, Spine, Journal of Hepatology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.